Qiagen Corp (QGEN) Long-Term Debt to Capital Ratio
The historical price action of Qiagen N.V. (QGEN) demonstrates the market trends of the company, whose indicator stands at 0.48. The business relies on laboratory automation and the production of unmanned test systems. Growth is accelerating through partnerships with research centers and pharma behemoths to create precision diagnostics. The company is currently implementing software robots for the digital analysis of genetic codes, having reached a peak in the mechanization of its assembly lines.
Comprehensive metric breakdowns and analytics for Qiagen N.V. (QGEN)
The stable cash flow of Qiagen N.V. (QGEN), driven by laboratory dependence on proprietary consumables for its instruments, enables effective management of the company's debt load. The long-term debt-to-equity ratio, reflected in the dynamics of debt with a maturity of over one year relative to equity, determines the business's financial resilience to systemic shocks, limiting default risks during market overheating by assessing the proportion of long-term loans.